AIM
AMPH icon

Ada Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Ada Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,109
Closed -$116K – 392
2015
Q3 		$116K Buy
+10,109
New +$152K 0.06% 439

Other funds holding AMPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ada Investment Management's AMPH Position: Q4 2015 in Review

Ada Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2015, closing a stake of 10,109 shares — an estimated $116K sold.

Ada Investment Management first reported a position in AMPH in Q3 2015 and held it in 1 quarter. The position peaked at $116K in Q3 2015. 95 funds tracked by Wall St. Rank hold AMPH as of Q4 2015.

  • Ada Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Ada Investment Management sold 10,109 Amphastar Pharmaceuticals shares in Q4 2015, an estimated $116K.
  • Ada Investment Management first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 1 quarter.
  • Ada Investment Management's Amphastar Pharmaceuticals position peaked at $116K in Q3 2015.
  • 95 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.